Tuberculous spondylitis in patients with end-stage renal disease undergoing chronic hemodialysis therapy — Report of two cases
- 34 Downloads
Tuberculous spondylitis is more common in patients with chronic renal failure who receive hemodialysis because of their abnormal T-cell-mediated immunity. It frequently poses both diagnostic and therapeutic challenges. We describe two cases of tuberculous spondylitis in patients undergoing chronic hemodialysis therapy. They are IFN-γ assay diagnosed (QuantiFERON-TB Gold) and conservatively treated. Our cases suggest that IFN-γ assays equip clinicians with more accurate tools for tuberculosis control. A combination of T-SPOT.TB testing and MRI assessment may be the accurate method to diagnose tuberculous spondylitis in patients with end-stage renal disease.
KeywordsTuberculous spondylitis End-stage renal disease IFN-γ assay Magnetic resonance imaging Antituberculous treatment
Unable to display preview. Download preview PDF.
- American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005, 172, 1169–1227CrossRefGoogle Scholar
- Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M: Detecting Latent Tuberculosis Infection in Hemodialysis Patients: A Head-to-Head Comparison of the T-SPOT.TB Test, Tuberculin Skin Test, and an Expert Physician Panel Clin J Am Soc Nephrol 2007, 2, 68–73Google Scholar
- Shankar MS, Aravindan AN, Sohal PM, Kohli HS, Sud K, Gupta KL, Sakhuja V, Jha V: The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: Tuberculin test and the risk of post-transplant tuberculosis. Nephrol Dial Transplant 2005, 20, 2720–2724CrossRefPubMedGoogle Scholar
- Aggarwal I: Tuberculosis — diagnosis and investigation. Hospital Pharmacist 2006, 13, 73–78Google Scholar